Bakshi Asha, Keck Carrie A, Koshkin Vadim S, LeBold David G, Siman Robert, Snyder Evan Y, McIntosh Tracy K
Traumatic Brain Injury Laboratory, Department of Neurosurgery, Philadelphia, PA 19104, USA.
Brain Res. 2005 Dec 14;1065(1-2):8-19. doi: 10.1016/j.brainres.2005.09.059. Epub 2005 Nov 23.
Neural progenitor cells (NPCs) have been shown to be a promising therapy for cell replacement and gene transfer in neurological diseases including traumatic brain injury (TBI). However, NPCs often survive poorly after transplantation despite immunosuppression, and the mechanisms of graft cell death are unknown. In this study, we evaluated caspase- and calpain-mediated mechanisms of cell death of neonatal mouse C17.2 progenitor cells, transplanted at 24 h following lateral fluid percussion brain injury (FP) in rats. Adult Male Sprague-Dawley rats (n = 30) were subjected to lateral FP injury (n = 18) or sham surgery (n = 12). C17.2 cells labeled with green fluorescent dye (CMFDA) were engrafted in the perilesional deep cortex, and animals were sacrificed at 24 h, 72 h and 1 week post-transplantation. Pro-apoptotic caspase-mediated cleavage products (Ab246) and calpain-mediated cleavage products (Ab38) were detected in the engrafted cells using immunohistochemistry. Only 2 to 4.5% of grafted NPCs were found to survive at 24 h post-transplantation, regardless of injury status of the host brain, although brain-injured animals had significantly fewer graft cells than sham-injured animals. Limited caspase and calpain-mediated graft cell death was observed in both sham- and brain-injured animals, and caspase-mediated graft cell death was significantly greater than calpain-mediated graft cell death in all animals. Brain-injured animals had significantly increased caspase-mediated graft cell death compared to sham-injured animals. These results suggest that both the caspase and calpain family of proteases are involved in graft cell death, and that caspase-mediated apoptotic graft cell death predominates in the acute post-traumatic period following TBI.
神经祖细胞(NPCs)已被证明是一种很有前景的治疗方法,可用于包括创伤性脑损伤(TBI)在内的神经疾病的细胞替代和基因转移。然而,尽管进行了免疫抑制,NPCs在移植后通常存活率很低,且移植细胞死亡的机制尚不清楚。在本研究中,我们评估了半胱天冬酶和钙蛋白酶介导的新生小鼠C17.2祖细胞的细胞死亡机制,这些细胞在大鼠侧方流体冲击性脑损伤(FP)后24小时进行移植。成年雄性Sprague-Dawley大鼠(n = 30)接受侧方FP损伤(n = 18)或假手术(n = 12)。用绿色荧光染料(CMFDA)标记的C17.2细胞植入损伤周边的深层皮质,动物在移植后24小时、72小时和1周处死。使用免疫组织化学在植入细胞中检测促凋亡半胱天冬酶介导的裂解产物(Ab246)和钙蛋白酶介导的裂解产物(Ab38)。无论宿主脑的损伤状态如何,移植后24小时仅发现2%至4.5%的移植NPCs存活,尽管脑损伤动物的移植细胞明显少于假损伤动物。在假手术和脑损伤动物中均观察到有限的半胱天冬酶和钙蛋白酶介导的移植细胞死亡,并且在所有动物中,半胱天冬酶介导的移植细胞死亡明显大于钙蛋白酶介导的移植细胞死亡。与假损伤动物相比,脑损伤动物的半胱天冬酶介导的移植细胞死亡明显增加。这些结果表明,蛋白酶的半胱天冬酶和钙蛋白酶家族均参与移植细胞死亡,并且在TBI后的急性创伤期,半胱天冬酶介导的凋亡性移植细胞死亡占主导。